Assessment of differential leukocyte count in patients with acute coronary syndrome

Journal of the Pakistan Medical Association

Volumn 60, Issue 7, 2010, Pages 548-551

  Munir, Tahir Ahmad ^a   Afzal, Mohammad Nasir ^b  

^a SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

^b Shalamar Medical and Dental College ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART MUSCLE INJURY; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; NEUTROPHIL COUNT; PAKISTAN; PATIENT ASSESSMENT; PREDICTION; PROGNOSIS;

EID: 77954519412     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003; 91: 3A-6A.
2. Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB; International Heart Collaborative (IHC) study group. Usefulness of high sensitivity C-reactive protein in predicting long term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 2002; 89: 145-9.
3. Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattisete PM, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial) sub study. J Am Coll Cardiol 2002; 40: 1761-8.
4. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt, DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long term mortality after percutaneous coronary intervention. Am J Cardiol 2006; 97: 993-6.
5. No author listed. Myocardial infarction redefined. A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13.
6. Brown DW, Giles WH, Croft JB. White blood cells count an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001; 54: 316-22.
7. Lee C, Folsom A, Nieto F, Chambless L, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women atherosclerosis risk in communities study. Am J Epidemiol 2001; 154: 758-64.
8. Haim M, Boyko V, Goldbourt U, Battler A, Behar S. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease the Bezafibrate Infarction Prevention Study. Arch Intern Med 2004; 164: 433-9.
9. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, et al; CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004; 35: 1147-52.
10. Afiune Neto A, Mansur Ade P, Avakian SD, Gomes EP, Ramires JÁ [Monocytosis is an independent risk marker for coronary artery disease.] Arq Bras Cardiol 2006; 86: 240-4.
11. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: athrombolysis in myocardial infarction 10 substudy. Circulation 2000; 102: 2329-34.
12. Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, et al. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 2006; 99: 891-9.
13. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, et al. CCL2/Monocyte Chemoattarctant Protein-1 regulates inflammatory responses critical to healing myocardial infarct. Circ Res 2005; 96: 881-9.
14. Choi YH, Lee WH, Lee Y, Kin JK, Lee SY, Park JE. Correlation between monocyte and T lymphocyte activation markers in patients with acute coronary syndrome. Jpn Heart J 2000; 41: 605-15.
15. Weyand CM, Coronzy JJ, Liuzzo G, Kopecky SL, Holmes DR, Frye RL. T cell immunity in acute coronary syndromes. Mayo Clin Proc 2001; 76: 1011-20.
16. Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004; 25: 1287-92.
17. Faxon DP, Gibbons RJ, Chronos NAF, Gurbel PA, Sheehan F; HALT-MI Investigators. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty the results of the HALT-MI study. J Am Coll Cardiol 2002; 40: 1199-204.
18. Hong YJ, Jeong MH, Ahn Y, Yoon NS, Lee SR, Hong SN, et al. Relationship between peripheral monocytosis and non recovery of left ventricular function in patients with left ventricular dysfunction complicated with acute myocardial infarction. Circ J 2007; 71: 1219-24.
19. Morimoto H, Takahashi M. Role of monocyte chemoattractant protein-1 in myocardial infarction. Int J Biomed Sci 2007; 3: 159-67.
20. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, et al. prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002; 39: 241-6.
21. Zazula AD, Precoma-Neto D, Gomes AM, Kruklis H, Barbieri GF, Forte RY, et al. An assessment of neutrophils/lymphocytes ratio in patients suspected of acute coronary syndrome. Arq Bras Cardiol 2008; 90: 31-6.